In the article “Osimertinib for Uncommon Endothelial Growth Factor Receptor-Mutant Non-Small Cell Lung Carcinoma: A Case Report” [Case Rep Oncol. 2024;17:1329–1334, https://doi.org/10.1159/000542201] by Popuri et al., the title of the article was wrongly given. The correct title is:
Osimertinib for Uncommon Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Carcinoma: A Case Report
The original title has been corrected.
